Literature DB >> 24105476

Sterol regulatory element-binding protein-1/fatty acid synthase involvement in proliferation inhibition and apoptosis promotion induced by progesterone in endometrial cancer.

Chunping Qiu1, Samina Dongol, Qing-Tao Lv, Ximei Gao, Jie Jiang.   

Abstract

BACKGROUND: The number of endometrial cancer (EC) cases is escalating rapidly, with no evident improvements in survival rates. The downregulation of progesterone receptor, resulting in progestin resistance, is presently a major problem regarding the therapeutic aspect. On the basis of this, we can focus more on the downstream signaling pathways that are controlled by progesterone. Lipid biosynthesis mediated by sterol regulatory element-binding protein-1/fatty acid synthase (SREBP-1/FASN) is of utmost importance to the growth and the proliferation of EC cells, so we hypothesize that SREBP-1/FASN might be involved in suppressing the proliferation and promoting apoptosis in EC cells through the effects induced by progesterone.
MATERIAL AND METHODS: The Cell Counting Kit-8 was used to analyze the growth inhibition ratio of Ishikawa cells upon treatment with megestrol acetate (MA; MA is a progesterone derivative, also known as 17α-acetoxy-6-dehydro-6-methylprogesterone) and to determine the 50% inhibitory concentration. Apoptosis ratio was analyzed by treatment of the cells with MA at 50% inhibitory concentration at different time intervals using Annexin V-FITC/propidium iodide. The protein and messenger RNA levels of SREBP-1 and FASN were compared between the experimental and control groups (MA-treated Ishikawa cells were considered to be the experimental group).
RESULTS: The experimental group showed obvious growth inhibition that was time and concentration dependent. The apoptosis ratio was also significantly higher in the experimental group compared with the control group (P < 0.01). The protein and messenger RNA levels of SREBP-1 and FASN were significantly reduced by MA too.
CONCLUSIONS: Sterol regulatory element-binding protein-1/FASN is involved in the proliferation suppression and apoptosis promotion brought about by MA in Ishikawa cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24105476     DOI: 10.1097/IGC.0000000000000004

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

1.  [6]-Gingerol inhibits de novo fatty acid synthesis and carnitine palmitoyltransferase-1 activity which triggers apoptosis in HepG2.

Authors:  Hathaichanok Impheng; Lysiane Richert; Dumrongsak Pekthong; C Norman Scholfield; Sutatip Pongcharoen; Ittipon Pungpetchara; Piyarat Srisawang
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

2.  MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.

Authors:  Xiao-Chen Wang; Xiao-Rong Zhan; Xin-Yu Li; Jun-Jie Yu; Xiao-Min Liu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 3.  Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.

Authors:  Ji Cheng; Tao Zhang; Hongbin Ji; Kaixiong Tao; Jianping Guo; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2016-09-25

4.  Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma.

Authors:  Xiaohong Ma; Tianyi Zhao; Hong Yan; Kui Guo; Zhiming Liu; Lina Wei; Wei Lu; Chunping Qiu; Jie Jiang
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

5.  Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line.

Authors:  Wenzhi Li; Shufen Wang; Chunping Qiu; Zhiming Liu; Qing Zhou; Deshui Kong; Xiaohong Ma; Jie Jiang
Journal:  J Transl Med       Date:  2019-02-27       Impact factor: 5.531

6.  Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer.

Authors:  Xin Li; Shuhong Gao; Wenzhi Li; Zhiming Liu; Zhengzheng Shi; Chunping Qiu; Jie Jiang
Journal:  J Obstet Gynaecol Res       Date:  2019-07-29       Impact factor: 1.730

7.  Hsa_Circ_0001860 Promotes Smad7 to Enhance MPA Resistance in Endometrial Cancer via miR-520h.

Authors:  Shuang Yuan; Panchan Zheng; Xiao Sun; Judan Zeng; Wenjiao Cao; Wuyuan Gao; Yudong Wang; Lihua Wang
Journal:  Front Cell Dev Biol       Date:  2021-11-29

8.  The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells.

Authors:  Javier A Menendez; Luciano Vellon; Ingrid Espinoza; Ruth Lupu
Journal:  Oncoscience       Date:  2016-07-22

9.  Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism.

Authors:  Mariona Jové; Sònia Gatius; Andree Yeramian; Manuel Portero-Otin; Núria Eritja; Maria Santacana; Eva Colas; Maria Ruiz; Reinald Pamplona; Xavier Matias-Guiu
Journal:  Oncotarget       Date:  2016-08-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.